Ambey Laboratories Ratios

Ambey Laboratories Ltd Ratios

The Ambey Laboratories Ltd Ratios page provides a complete fundamental analysis of Ambey Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Ambey Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Ambey Laboratories Ltd (NSE: AMBEY, BSE: 92828) is currently trading at ₹33.15, with a market capitalization of ₹869.4M. As a major player in the Process industries sector and Chemicals: agricultural industry, Ambey Laboratories Ltd remains a key stock for fundamental analysis using Ambey Laboratories Ltd Ratios.

Ambey Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Ambey Laboratories Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Ambey Laboratories Ltd Ratios.

Historically, the Ambey Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Ambey Laboratories Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Ambey Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Ambey Laboratories Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Ambey Laboratories Ltd P/S ratio currently stands at 0, an important part of Ambey Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Ambey Laboratories Ltd P/S ratio indicates cautious market sentiment.

Ambey Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Ambey Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Ambey Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The declining Ambey Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Ambey Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Ambey Laboratories Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Ambey Laboratories Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Ambey Laboratories Ltd EV/EBITDA ratio is currently 0, a key metric in Ambey Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable Ambey Laboratories Ltd EV/EBITDA indicates balanced valuation.

Ambey Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Ambey Laboratories Ltd D/E ratio is currently 0.53, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.53
• 2023: 0.94
• 2022: 0.58
• 2021: 0.95

Ambey Laboratories Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Ambey Laboratories Ltd ROE currently stands at 8.87%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 8.87
• 2023: 28
• 2022: 21.40
• 2021: 63.82

Declining ROE indicates pressure on profitability.

Ambey Laboratories Ltd Ratios Analysis Summary

The Ambey Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Ambey Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Ambey Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.